Skip to main content
. 2018 Aug 10;8:11955. doi: 10.1038/s41598-018-29878-6

Figure 6.

Figure 6

Silencing AEBP1 results in the inhibition of epithelial-mesenchymal transition (EMT) by downregulating the NF-κB pathway. (A) qRT-PCR and (B) Western blotting analyses of EMT-related markers (E-cadherin, MMP2, MMP9, snail and vimentin) in AEBP1-knockdown and mock cells; *P < 0.05; **P < 0.01, ***P < 0.001. (C) Protein levels of p65, p-p65, IκBα and p-ERK1/2 in AEBP1-knockdown and mock cells. (D) Nuclear protein expression of NF-κB p65 in AEBP1-knockdown and mock cells. (E) Western blotting analyses of p65 and p-p65 expression in xenograft tumors derived from the AEBP1-knockdown and mock MGC803 and XN0422 cells. (F) Protein levels of two NF-κB downstream targets (CXCR4 and ICAM1) in AEBP1-knockdown and mock cells. The western blots were derived under the same experimental conditions from the same cell lysates; the original full-length Western blot images are shown in Supplementary Fig. S5.